Rating History for FibroBiologics (FBLG) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/26/2026 | Matthew Caufield | Maintain | Buy (N/A) |
4.00 (5.00) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/26/2026 | Matthew Caufield | Maintain | Buy (N/A) |
4.00 (5.00) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||